Medication nonadherence and substance abuse in psychotic disorders - Impact of depressive symptoms and social stability

被引:31
作者
Elbogen, EB [1 ]
Swanson, JW [1 ]
Swartz, MS [1 ]
Van Dorn, R [1 ]
机构
[1] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27710 USA
关键词
medication nonadherence; psychotic disorders; substance abuse; depression; living instability;
D O I
10.1097/01.nmd.0000180742.51075.70
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Although studies have consistently shown a strong relationship between medication nonadherence and substance abuse in psychotic disorders, less is understood about the mechanisms underlying this relationship. The purpose of this study was to examine whether the relationship between substance abuse and medication nonadherence in psychosis is mediated by depressive symptoms and social stability. Participants interviewed (N = 528) were adults with schizophrenia and related disorders receiving public mental health services in four US states. Multivariate analyses showed substance abuse, depressive symptoms, and living stability each contributed to medication nonadherence; thus, the relationship between substance abuse and medication adherence in psychotic disorders did not appear to be mediated by the selected variables. Instead, a robust association between depressive symptoms and medication adherence was found, attesting to the utility of assessing for depression when evaluating adherence among people with psychosis. Living instability was common and related to medication nonadherence, too, warranting further investigation.
引用
收藏
页码:673 / 679
页数:7
相关论文
共 48 条
[1]   Nonadherence among HIV-Infected injecting drug users: The impact of social instability [J].
Bouhnik, AD ;
Chesney, M ;
Carrieri, P ;
Gallais, H ;
Moreau, J ;
Moatti, JP ;
Obadia, Y ;
Spire, B .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 31 :S149-S153
[2]  
CHEN A, 1991, HOSP COMMUNITY PSYCH, V42, P282
[3]   Depression and diabetes -: Impact of depression symptoms on adherence, function, costs [J].
Ciechanowski, PS ;
Katon, WJ ;
Russo, JE .
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (21) :3278-3285
[4]   Awareness of illness in schizophrenia and outpatient treatment adherence [J].
Cuffel, BJ ;
Alford, J ;
Fischer, EP ;
Owen, RR .
JOURNAL OF NERVOUS AND MENTAL DISEASE, 1996, 184 (11) :653-659
[5]   Depression is a risk factor for noncompliance with medical treatment -: Meta-analysis of the effects of anxiety and depression on patient adherence [J].
DiMatteo, MR ;
Lepper, HS ;
Croghan, TW .
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (14) :2101-2107
[6]   Variables associated with disparities in treatment of patients with schizophrenia and comorbid mood and anxiety disorders [J].
Dixon, L ;
Green-Paden, L ;
Delahanty, J ;
Lucksted, A ;
Postrado, L ;
Hall, J .
PSYCHIATRIC SERVICES, 2001, 52 (09) :1216-1222
[7]  
ENDICOTT J, 1976, ARCH GEN PSYCHIAT, V33, P766
[8]   Risk factors for HIV, hepatitis B, and hepatitis C among persons with severe mental illness [J].
Essock, SM ;
Dowden, S ;
Constantine, NT ;
Katz, L ;
Swartz, MS ;
Meador, KG ;
Osher, FC ;
Rosenberg, SD .
PSYCHIATRIC SERVICES, 2003, 54 (06) :836-841
[9]   Determinants of medication compliance in schizophrenia: Empirical and clinical findings [J].
Fenton, WS ;
Blyler, CR ;
Heinssen, RK .
SCHIZOPHRENIA BULLETIN, 1997, 23 (04) :637-651
[10]  
First M. B., STRUCTURED CLIN INTE